期刊文献+

宁心宝胶囊定性定量方法研究 被引量:1

Study on qualitive and quantitative methods of Ningxinbao capsules
原文传递
导出
摘要 目的:建立宁心宝胶囊的定性定量方法。方法:采用TLC法对该制剂中的游离麦角甾醇类成分及核苷类成分分别进行定性鉴别;采用HPLC法对3种核苷类成分尿苷、鸟苷及腺苷进行定量分析,色谱柱为Lichrospher C18(250mm×4.6mm,5μm)柱,流动相为甲醇-0.05moL·L-1磷酸二氢钾溶液(8∶92),流速1.0mL.min-1,检测波长260nm。结果:游离麦角甾醇类及核苷类成分的TLC定性鉴别专属性强。HPLC法测定的尿苷、鸟苷、腺苷3种核苷类成分的线性范围分别为0.13~1.90μg(r=0.9999,n=5),0.09~1.30μg(r=0.9999,n=5),0.08~1.21μg(r=0.9999,n=5);平均回收率(n=9)分别为100.8%,99.4%,100.9%。结论:本方法定性专属性强,定量准确可靠,方法操作简便,灵敏度高,可用于控制宁心宝胶囊的质量。 Objective:To establish the quality and quantity methods of Ningxinbao capsules. Methods: Ergosterins and nucleosides in Ningxinbao capsules were identified by TLC. The contents of three nucleosides (uridine, guanosine, adenosine) in Ningxinbao capsules were determined simultaneously by HPLC. The chromatographic col- umn was Lichrospher Cts column(250 mm ×4. 6 mm ,5 μm) ;The mobile phase was methanol -0. 05 mol · L-1 po- tassium dihydrogen phosphate solution (8:92) at the flow rate of 1.0 mL ·min-1 , and the detecting wavelength was 260 nm. Results:The method of identifying ergosterins and nucleosides was specific. The calibration curves were linear in the ranges of 0. 13 - l. 90 μg(r =0. 9999,n =5) for uridine,0. 09 - 1.30 μg(r =0. 9999,n =5) for guanosine, and 0. 08 -1.21μg(r =0. 9999,n =5) for adenosine;The average recoveries(n =9) were 100. 8%, 99. 4% and 100. 9% respectively. Conclusion: The method is specific, effective, sensitive and accurate. It can be used for quality control of Ningxinbao capsules.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第9期1430-1434,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 宁心宝胶囊 尿苷 鸟苷 腺苷 薄层色谱法 高效液相色谱法 Ningxinbao capsules uridine guanosine adenosine TLC HPLC
  • 相关文献

参考文献7

二级参考文献34

  • 1黄兰芳,郭方遒,梁逸曾,陈本美.HPLC-ESI-MS测定冬虫夏草和蚕蛹虫草中腺苷和虫草素含量[J].中国中药杂志,2004,29(8):762-764. 被引量:69
  • 2尚德静,王孝敏.冬虫夏草深层发酵的研究[J].中国食用菌,1996,15(6):48-49. 被引量:24
  • 3小林义雄 清水大典.冬虫夏草菌图谱[M].大阪:保育社,1983.163-165.
  • 4中华人国共和国卫生部药典委员会.中华人民共和国卫生部药品标准中药成方制剂:第十一册[M].,1998..
  • 5Shiao M S,Bot Bull Acad Sin,1994年,35卷,4期,261页
  • 6Zhang D G,药物分析杂志,1987年,7卷,1期,6页
  • 7YQ Q C, NING W, LIANG H Q, et al. Determination of the anmorph of Cordyceps sinensis inferred from the analysis oh the ribosomal DNA internal transcribed spacers and 5.8S rDNA[J]. Biochemical Systematics and Ecology, 2001, 29:597 - 607.
  • 8ZHU J S, HALPERN G M, JONES K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis. Part Ⅰ[J]. The Journal of Alternative and complementary Medicine, 1998a, 4(3) :289 - 303.
  • 9ZHU J S, HALPERN G M, JONES K. The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis. Part Ⅱ[J]. The Journal of Alternative and complementary Medicine, 1998b, 4(4) :429 - 457.
  • 10JIN W B, LEONARD L, JEFF Ch. Antitumor sterols from the mycelia of Cordyceps sinensi [J]. Phytochemistry, 1999,51: 891 - 898.

共引文献137

同被引文献14

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部